Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Pharmacovigilance Case Intake

Posted on By

SOP for Pharmacovigilance Case Intake

Guidelines for Intake of Pharmacovigilance Cases

1) Purpose

The purpose of this SOP is to establish standardized procedures for the intake of pharmacovigilance cases to ensure timely and accurate initial data capture for adverse event reports and other safety information.

2) Scope

This SOP applies to all pharmacovigilance personnel involved in the intake of case reports, including data entry operators, safety specialists, and managers.

3) Responsibilities

The Case Intake Team is responsible for the initial handling and logging of pharmacovigilance cases. The Pharmacovigilance (PV) Manager oversees the process to ensure compliance with regulatory requirements and internal standards.

4) Procedure

4.1 Receipt of Case Reports

  1. Receive case reports through various channels, such as email, fax, phone, or electronic reporting systems.
  2. Acknowledge receipt of the case report promptly, confirming the sender’s details and the date of receipt.
  3. Ensure all relevant information is included in the initial case report. If information is missing, contact the sender for clarification.
See also  SOP for Pharmacovigilance Periodic Reporting

4.2 Initial Case Logging

  1. Assign a unique case identifier to each new report for tracking and reference purposes.
  2. Log the case details into the pharmacovigilance database, including patient information, adverse event details, and reporter information.
  3. Verify the accuracy and completeness of the logged information.

4.3 Triage and Prioritization

  1. Assess the case to determine its seriousness and urgency based
on predefined criteria.
  • Prioritize cases that require immediate action, such as serious adverse events or events involving special populations (e.g., pregnant women, children).
  • Document the triage assessment and prioritization decision in the case file.
  • 4.4 Preliminary Data Entry

    1. Enter the initial case information into the pharmacovigilance database using standardized forms and coding systems.
    2. Ensure accurate and consistent data entry to facilitate further case processing and analysis.
    3. Perform a preliminary review to identify any obvious data discrepancies or missing information.

    4.5 Follow-Up Information

    1. Identify cases that require follow-up information to complete the initial report.
    2. Send follow-up requests to the appropriate sources, documenting all communications.
    3. Update the case file with any new information received and reassess the case as necessary.

    4.6 Quality Control

    1. Conduct regular quality control checks on case intake activities to ensure accuracy and completeness.
    2. Address any issues or errors identified during quality control checks promptly.
    3. Document all quality control activities and any corrective actions taken.

    4.7 Documentation and Record Keeping

    1. Maintain detailed records of all case intake activities, including initial case reports, follow-up logs, and quality control reports.
    2. Ensure all documentation is securely stored and easily accessible for audits and inspections.
    3. Keep a log of all data corrections and updates made during the case intake process.

    4.8 Communication

    1. Communicate case intake procedures and updates to all relevant staff members.
    2. Provide training on case intake tools and methods to ensure consistency and accuracy.
    3. Report any issues or challenges encountered during case intake to the PV Manager.

    5) Abbreviations, if any

    PV – Pharmacovigilance

    6) Documents, if any

    Initial case reports, follow-up logs, quality control reports.

    7) Reference, if any

    ICH E2E Pharmacovigilance Planning, EU Good Pharmacovigilance Practices (GVP) Module VI.

    8) SOP Version

    Version 1.0

    See also  SOP for Pharmacovigilance Compliance Monitoring Plan
    Pharmacovigilance Tags:Pharmacovigilance adverse event reporting SOP, Pharmacovigilance audit preparation SOP, Pharmacovigilance case processing SOP, Pharmacovigilance compliance monitoring SOP, Pharmacovigilance compliance SOP, Pharmacovigilance data collection SOP, Pharmacovigilance data privacy SOP, Pharmacovigilance database management SOP, Pharmacovigilance documentation management SOP, Pharmacovigilance guidelines, Pharmacovigilance literature review SOP, Pharmacovigilance medical review SOP, Pharmacovigilance periodic reporting SOP, Pharmacovigilance procedure document, Pharmacovigilance quality management SOP, Pharmacovigilance regulatory reporting SOP, Pharmacovigilance risk assessment SOP, Pharmacovigilance risk management plan SOP, Pharmacovigilance risk minimization SOP, Pharmacovigilance safety reporting SOP, Pharmacovigilance signal detection SOP, Pharmacovigilance signal management SOP, Pharmacovigilance SOP template, Pharmacovigilance system master file SOP, Pharmacovigilance training program SOP

    Post navigation

    Previous Post: SOP for Analytical Method Development Dissolution Method Development
    Next Post: SOP for Formulation Development Raw Material Specification Development

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version